[TruScreen Combined With High-Risk Human Papillomavirus Testing vs Thinprep Cytology Test Combined With High-Risk Human Papillomavirus Testing for Cervical Cancer Screening: A Comparative Clinical Study].
TruScreen combined with hr-HPV test demonstrates superior performance in cervical cancer screening compared with TCT combined with hr-HPV test. TruScreen combined with hr-HPV test may serve as an alternative to conventional cytology-based methods for cervical cancer screening in China.
Authors
- Dengpan Wang
- Liyin Zhang
- Yifeng Wang (ORCID: https://orcid.org/0000-0001-5708-0951)
- Chunmei Li (ORCID: https://orcid.org/0000-0001-8227-9719)
- Shuyun Jia
- Yi Yang (ORCID: https://orcid.org/0000-0003-2879-4968)
Institutions
- Panzhihua Central Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2025-05-20
- DOI
- https://doi.org/10.12182/20250560609
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00